FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a...
-
Upload
dominick-paul -
Category
Documents
-
view
214 -
download
0
Transcript of FFAG F ixed F ield A lternating G radient Synchrotrons A new type of particle accelerator - with a...
FFixed FField AAlternating GGradient Synchrotrons
A new type of particle accelerator - with a wide variety of applications
Cancer Therapy and UK Activities
Current Cancer Therapy Projects
We are seeking collaborators to work with us on the development of this novel form of accelerator for proton and carbon ion therapy!
A second type of FFAG
A magnet for the prototype 150 MeV scaling FFAG built at KEK. The
magnets for a non-scaling FFAG could have a 10 times smaller
aperture, making them smaller and cheaper.
The orbit shape in scaling FFAG cells is the same at each energy, but varies with non-scaling machines. This allows the apertures of the magnets to be much smaller in the latter, reducing the cost for the same performance.
There are two types of FFAG envisaged. All those built or under construction so far are so-called "scaling" FFAGs in which the orbits of particles around the machine are the same, except they scale with energy. The problem with this is the magnets required tend to be large and complex, and hence expensive. This
The second type is a "non-scaling" FFAG, in which the orbit shapes change as a function of energy. This allows the apertures of the magnets to be up to 10 times smaller than for a scaling machine, making the FFAG much more compact. In addition, the non-scaling magnets are less complex. Taken together, these should make a non-scaling machine considerably cheaper than a scaling machine for the same performance, bringing a sea change in accelerator technology.
However, non-scaling FFAGs have three unique features which must be investigated before their wide-spread use can be envisaged. To do this, it is planned to build an electron “model” non-scaling FFAG, the first of this type ever built, and study these features in detail.
What are we planning to do in the UK?Accelerator scientists from the UK started working on scaling FFAGs about 2 years ago and have been investigating the use of these machines for a variety of applications. More recently, we have become interested in non-scaling FFAGs and in particular the electron model non-scaling FFAG. It is now proposed to build this unique machine at the Daresbury Laboratory in Cheshire, in collaboration with colleagues from Europe, Japan and the US. Existing infrastructure at Daresbury will be used to provide the electron beam. In addition, we will continue to investigate the utility of both types of FFAGs for a variety of applications, in particular hadron therapy. Funding for these activities is being sought from a number of sources.
If successful, the electron model FFAG will initiate a revolution in future accelerator design!
FFAGs are ideal for cancer therapyFFAGs are a new type of accelerator with properties that lead to wide variety of possible applications, in particular cancer therapy:
they can be used to accelerate protons, electrons and ions
they can be rapidly cycled, much faster than a synchrotron
they have a large acceptance for a particle beam, much bigger than a synchrotron
they have very small beam loss and low activation, smaller than a cyclotron
they are easy to maintain
they can have a very large intensity
they consist of a magnetic ring and do not require the same large magnets as cyclotrons
they do not have the same restrictions on energy as a cyclotron
beam can be extracted at a number of energies
they are reliable
they are easy to operate
Benefits of FFAGs for Proton and Carbon Therapy To extend the use of proton and ion therapy, in particular into major hospitals, there are a number of requirements that must be satisfied:
Efficient treatment• at least 500 patients per year
High dose rate• at least 5Gy per minute to provide sufficient flexibility
Flexibility (for various types of cancer)• the ability to run in respiration mode to treat as many types of tumour as possible• the ability to use spot scanning• a variable beam energy to reduce the need for absorbers• the possibility of using carbon ions as well as protons
Easy operation
Easy maintainability• low activation of the accelerator components to enable easy access
Low cost• both during construction and operation
Synchrotron Cyclotron FFAG
Beam intensity Low Plenty Plenty
Maintenance Normal Hard Normal
Operation Not easy Easy Easy
Carbon ions possible Yes Expensive Yes
Variable energy possible Yes No Yes
Multiple beam extraction Difficult No Yes
Comparison between Accelerator Technologies for Proton and Ion Therapy
Ibaraki proton therapy facility (Jp) 230 P 2.2-4.1 20 0.1A
MEICo – radiation therapy prototype (Jp) 1 E 0.02-0.03 1000
MEICo – carbon ion therapy (Jp) 400 C6+ 7.0-7.5 0.5
7 C4+ 1.4-1.8 0.5
MEICo – proton therapy (Jp) 230 p 0.0-0.7 2000 Superconducting
NIRS Chiba – carbon ion therapy (Jp) 400 C6+ 10.1-10.8 200
100 C6+ 5.9-6.7 200
7 C4+ 2.1-2.9 200
KURRI - Boron Neutron Capture Therapy (Jp) 10 p 1.5-1.6 >20mA
BNL – Proton therapy FFAG (US) 250 P 5.3-5.4 1000
E (MeV) Ion Radius (m) Rep rate (Hz)
Comments/1st beam
KEK – proton therapy prototype (Jp) 150 p 4.5-5.2 2003
All but the last are in Japan. The last differs from the others in another respect as well: it is a different type of FFAG. See below………
The KEK proton therapy prototype.
The three FFAG rings of the Chiba ion therapy facility.
The old tandem van der Graaf at the Daresbury Laboratory.
The Energy Recovery Linac Prototype is being built in two of the experimental halls of the van der Graaf. This will provide beams
for the FFAG model, which will also be in one of these halls.
The following projects are under development using FFAGs
Current FFAGs have excellent properties for
Hadron Therapy but further improvements are
still possible
may hamper their use in medicine and industry.
EMMAEMMA